PubMed:10781596
Annnotations
GGDB-2020
{"project":"GGDB-2020","denotations":[{"id":"T1","span":{"begin":137,"end":143},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T2","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T3","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T4","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T5","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T6","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T7","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T8","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T9","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T10","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T11","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T12","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T13","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T14","span":{"begin":1045,"end":1051},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T15","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T16","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T17","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T18","span":{"begin":1130,"end":1136},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T19","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T20","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T21","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T22","span":{"begin":1376,"end":1382},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T23","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T24","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T25","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg028"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
ggdb-test
{"project":"ggdb-test","denotations":[{"id":"T1","span":{"begin":137,"end":143},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T2","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T3","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T4","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T5","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T6","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T7","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T8","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T9","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T10","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T11","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T12","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T13","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T14","span":{"begin":1045,"end":1051},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T15","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T16","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T17","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T18","span":{"begin":1130,"end":1136},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T19","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T20","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T21","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"T22","span":{"begin":1376,"end":1382},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"T23","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"T24","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"T25","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg025"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
GlyCosmos6-Glycan-Motif-Image
{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":44,"end":55},"obj":"Glycan_Motif"},{"id":"T2","span":{"begin":92,"end":103},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":255,"end":266},"obj":"Glycan_Motif"},{"id":"T4","span":{"begin":747,"end":758},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":773,"end":788},"obj":"Glycan_Motif"},{"id":"T6","span":{"begin":1011,"end":1022},"obj":"Glycan_Motif"},{"id":"T7","span":{"begin":1086,"end":1107},"obj":"Glycan_Motif"},{"id":"T8","span":{"begin":1531,"end":1542},"obj":"Glycan_Motif"},{"id":"T9","span":{"begin":1584,"end":1605},"obj":"Glycan_Motif"},{"id":"T10","span":{"begin":1584,"end":1595},"obj":"Glycan_Motif"},{"id":"T11","span":{"begin":1715,"end":1726},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A4","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G82109MW"},{"id":"A6","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A7","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G27025MB"},{"id":"A8","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A9","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G34992DF"},{"id":"A10","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"},{"id":"A11","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Glycosmos6-GlycoEpitope
{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":44,"end":55},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T2","span":{"begin":92,"end":103},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T3","span":{"begin":255,"end":266},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T4","span":{"begin":747,"end":758},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T5","span":{"begin":773,"end":788},"obj":"http://www.glycoepitope.jp/epitopes/EP0085"},{"id":"T6","span":{"begin":1011,"end":1022},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T7","span":{"begin":1531,"end":1542},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T8","span":{"begin":1584,"end":1605},"obj":"http://www.glycoepitope.jp/epitopes/EP0083"},{"id":"T9","span":{"begin":1584,"end":1595},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T10","span":{"begin":1715,"end":1726},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
sentences
{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":77},"obj":"Sentence"},{"id":"T2","span":{"begin":78,"end":308},"obj":"Sentence"},{"id":"T3","span":{"begin":309,"end":448},"obj":"Sentence"},{"id":"T4","span":{"begin":449,"end":599},"obj":"Sentence"},{"id":"T5","span":{"begin":600,"end":759},"obj":"Sentence"},{"id":"T6","span":{"begin":760,"end":930},"obj":"Sentence"},{"id":"T7","span":{"begin":931,"end":1108},"obj":"Sentence"},{"id":"T8","span":{"begin":1109,"end":1201},"obj":"Sentence"},{"id":"T9","span":{"begin":1202,"end":1306},"obj":"Sentence"},{"id":"T10","span":{"begin":1307,"end":1490},"obj":"Sentence"},{"id":"T11","span":{"begin":1491,"end":1809},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
GlyCosmos6-Glycan-Motif-Structure
{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":44,"end":55},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T2","span":{"begin":92,"end":103},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T3","span":{"begin":255,"end":266},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T4","span":{"begin":747,"end":758},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T5","span":{"begin":773,"end":788},"obj":"https://glytoucan.org/Structures/Glycans/G82109MW"},{"id":"T6","span":{"begin":1011,"end":1022},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T7","span":{"begin":1086,"end":1107},"obj":"https://glytoucan.org/Structures/Glycans/G27025MB"},{"id":"T8","span":{"begin":1531,"end":1542},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T9","span":{"begin":1584,"end":1605},"obj":"https://glytoucan.org/Structures/Glycans/G34992DF"},{"id":"T10","span":{"begin":1584,"end":1595},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"},{"id":"T11","span":{"begin":1715,"end":1726},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Glycosmos6-MAT
{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":1234,"end":1239},"obj":"http://purl.obolibrary.org/obo/MAT_0000098"},{"id":"T2","span":{"begin":1483,"end":1489},"obj":"http://purl.obolibrary.org/obo/MAT_0000085"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
glycogenes
{"project":"glycogenes","denotations":[{"id":"PD-GlycoGenes20190927-B_T1","span":{"begin":126,"end":136},"obj":"url"},{"id":"PD-GlycoGenes20190927-B_T2","span":{"begin":137,"end":143},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"PD-GlycoGenes20190927-B_T3","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T4","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T5","span":{"begin":137,"end":141},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T6","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T7","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T8","span":{"begin":289,"end":293},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T9","span":{"begin":414,"end":416},"obj":"https://acgg.asia/db/ggdb/info/gg111"},{"id":"PD-GlycoGenes20190927-B_T10","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T11","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T12","span":{"begin":509,"end":513},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T13","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T14","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T15","span":{"begin":895,"end":899},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T16","span":{"begin":1045,"end":1051},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"PD-GlycoGenes20190927-B_T17","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T18","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T19","span":{"begin":1045,"end":1049},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T20","span":{"begin":1130,"end":1136},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"PD-GlycoGenes20190927-B_T21","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T22","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T23","span":{"begin":1130,"end":1134},"obj":"https://acgg.asia/db/ggdb/info/gg025"},{"id":"PD-GlycoGenes20190927-B_T24","span":{"begin":1376,"end":1382},"obj":"https://acgg.asia/db/ggdb/info/gg026"},{"id":"PD-GlycoGenes20190927-B_T25","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg028"},{"id":"PD-GlycoGenes20190927-B_T26","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg027"},{"id":"PD-GlycoGenes20190927-B_T27","span":{"begin":1376,"end":1380},"obj":"https://acgg.asia/db/ggdb/info/gg025"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Anatomy-MAT
{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":1234,"end":1239},"obj":"Body_part"},{"id":"T2","span":{"begin":1483,"end":1489},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000098"},{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000085"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
NCBITAXON
{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":86,"end":91},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":249,"end":254},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":503,"end":508},"obj":"OrganismTaxon"},{"id":"T4","span":{"begin":1228,"end":1233},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"},{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"},{"id":"A3","pred":"db_id","subj":"T3","obj":"9606"},{"id":"A4","pred":"db_id","subj":"T4","obj":"9606"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Glycosmos15-GlycoEpitope
{"project":"Glycosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":44,"end":55},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":92,"end":103},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":255,"end":266},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T4","span":{"begin":747,"end":758},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T5","span":{"begin":773,"end":788},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T6","span":{"begin":1011,"end":1022},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T7","span":{"begin":1531,"end":1542},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T8","span":{"begin":1584,"end":1605},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T9","span":{"begin":1715,"end":1726},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A4","pred":"glycoepitope_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0085"},{"id":"A6","pred":"glycoepitope_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A7","pred":"glycoepitope_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A8","pred":"glycoepitope_id","subj":"T8","obj":"http://www.glycoepitope.jp/epitopes/EP0083"},{"id":"A9","pred":"glycoepitope_id","subj":"T9","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":417,"end":430},"obj":"Body_part"},{"id":"T2","span":{"begin":1185,"end":1195},"obj":"Body_part"},{"id":"T3","span":{"begin":1234,"end":1239},"obj":"Body_part"},{"id":"T5","span":{"begin":1483,"end":1489},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/GO_0016020"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/GO_0005694"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A4","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_6110636"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002106"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}
Glycosmos15-CL
{"project":"Glycosmos15-CL","denotations":[{"id":"T1","span":{"begin":1240,"end":1244},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000096"},{"id":"A2","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase.\nA novel human chondroitin 6-O-sulfotransferase, designated C6ST-2, was identified by BLAST analysis of expressed sequence tag using the sequence of a previously described human chondroitin 6-O-sulfotransferase (C6ST-1) as a probe. The new cDNA sequence revealed an open reading frame coding for a protein of 486 amino acids with a type II transmembrane protein topology. The amino acid sequence displayed 24% identity to the human C6ST-1, and the highest sequence identity was found in the COOH-terminal catalytic domain. The expression of a soluble recombinant form of the protein in COS-1 cells produced an active sulfotransferase with marked specificity for polymer chondroitin. In contrast, keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc sequence, which are good acceptor substrates for the C6ST-1, hardly served as acceptors. The identification of the reaction product indicated that the enzyme is a novel chondroitin 6-O-sulfotransferase (C6ST-2) that mainly transfers sulfate to N-acetylgalactosamine. The coding region of C6ST-2 was contained in a single exon and localized to chromosome Xp11. Northern blot analysis of human brain poly(A)(+) RNA revealed a single transcript of 2.4 kilobase pairs. Reverse transcription-polymerase chain reaction analysis showed that C6ST-2 is developmentally regulated in various tissues with expression persisting through adulthood in the spleen. Thus, we demonstrated the redundancy in chondroitin 6-O-sulfotransferases capable of forming chondroitin 6-sulfate, which is important for understanding the mechanisms leading to specific changes in the sulfation profile of chondroitin sulfate chains in various tissues during development and malignant transformation."}